Anzeige
Mehr »
Login
Dienstag, 28.09.2021 Börsentäglich über 12.000 News von 673 internationalen Medien
Kurschance? Countdown mit Ansage: Last Call!?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14R82 ISIN: BE0974281132 Ticker-Symbol: 8XB 
Stuttgart
28.09.21
08:08 Uhr
3,895 Euro
-0,010
-0,26 %
Branche
Gesundheitswesen
Aktienmarkt
BEL Mid
1-Jahres-Chart
BIOCARTIS GROUP NV Chart 1 Jahr
5-Tage-Chart
BIOCARTIS GROUP NV 5-Tage-Chart
RealtimeGeldBriefZeit
3,9053,94012:55

Aktuelle News zur BIOCARTIS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoBiocartis Group NV: Biocartis Announces Restart of its High-Throughput Cartridge Manufacturing Line2
BIOCARTIS Aktie jetzt für 0€ handeln
13.09.Biocartis Group NV: Disclosure of a transparency notification1
02.09.Biocartis Group NV: Biocartis announces H1 2021 results2
02.09.Biocartis NV: Press news Biocartis Group NV: Biocartis Launches Idylla SARS-CoV-2/Flu/RSV Panel1
30.08.Biocartis Group NV: Disclosure of a transparency notification1
26.08.Biocartis Group NV: BIOCARTIS ANNOUNCES 2021 HALF-YEAR RESULTS ON 2 SEPTEMBER 20211
17.08.Biocartis Group NV: Second Update on Fire Incident at Biocartis Warehouse2
02.08.Biocartis NV: Press news Biocartis Group NV: Update on Fire Incident at Biocartis Warehouse6
31.07.Biocartis NV: Press news Biocartis Group NV: Fire Incident at Biocartis Warehouse in Mechelen, Belgium2
04.06.Biocartis Group NV: Results of the Extraordinary Shareholders' Meeting held on 4 June 20215
17.05.Biocartis Group NV: Invitation to the Extraordinary Shareholders' Meeting6
14.05.Biocartis Group NV: Results of the Shareholders' Meetings held on 14 May 20213
11.05.Biocartis Group NV: Biocartis Receives EUR 1.4m Grant to Support Development of New Idylla Technology to Unlock Potential ...2
04.05.Biocartis, AstraZeneca Expand Availability Of Idylla EGFR Biomarker Testing In Lung Cancer284LONDON (dpa-AFX) - Biocartis Group NV said it signed a new agreement with AstraZeneca (AZN, AZN.L), aiming to provide access to rapid and easy-to-use Idylla EGFR testing products at selected...
► Artikel lesen
04.05.Biocartis NV: Press news Biocartis Group NV: Biocartis Announces New Collaboration with AstraZeneca to Expand Availability of Idylla EGFR Biomarker Testing ...3
22.04.Biocartis Group NV: Biocartis and SkylineDx Sign Collaboration to Develop the Merlin Assay, a Test Predicting Risk for Nodal ...4
20.04.Biocartis Group NV: Biocartis Announces US FDA 510(k) submission of its Idylla MSI Test4
13.04.Biocartis Group NV: Invitation to the Annual and Extraordinary Shareholders' Meetings3
01.04.Biocartis Group NV: Biocartis Announces Publication of 2020 Annual Report4
29.01.Technavio Research: Influenza Diagnostics Market 2020-2024- Abbott Laboratories, Biocartis Group NV, Bio-Rad Laboratories Inc., Among Others to Contribute to the Market Growth | Industry Analysis, Market Trends, Opportunities and Forecast 2024 | Technavio477The influenza diagnostics market is poised to grow by 1.32 bn during 2020-2024, decelerating at a CAGR of almost 10% during the forecast period. This press release features multimedia. View the full...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1